Delivery Order SPE2DB24D2205-SPE2DB25FDZCS

Award Date 3/4/25
Potential Completion Date 3/5/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,548.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product, to support military and federal healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,375.52, is a delivery order for a medical product described as "CIPRO 5% SUSPENSION 100ML." The contract has a firm fixed-price pricing type and an ultimate completion date of June 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,232.49, is for the delivery of CIPRO 5% SUSPENSION 100ML medical supplies. The contract has an ultimate completion date of March 6, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,893.05, is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. The contract provides for the delivery of CIPRO 500 MG TABLET 100S, a pharmaceutical product, to...
This federal contract award, valued at $3,387.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4557942522 - CIPROFLOXACIN HCL 250 MG TAB 100S, and has a completion date of August 1, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $1,655.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,463.78 firm fixed-price contract is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product, with a period of performance through June 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,783.38 firm-fixed-price delivery order is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024 and was awarded on August 23, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major supplier of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,159.14, is a delivery order for 4565076616 CIPRO 500 MG TABLET 100S. The contract has a firm fixed price and an ultimate completion date of July 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DX15D2217|SPE2DX24F67KG, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,271.50 firm fixed-price delivery order is for the supply of CIPRO 5% SUSPENSION 100ML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of June 14, 2024. Amerisourcebergen holds a significant...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDZCS
    Delivery Order

This federal contract award, valued at $2,097.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product, with a period of performance through March 5, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

This contract award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen's extensive federal contract portfolio demonstrates its key role in supplying essential pharmaceutical and medical products to various government agencies, particularly the DLA, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/3/25, 9:48 AM